cancer vaccine
| 5 min read
Therapeutic cancer vaccines are being reengineered to deliver stronger immune activation and longer-lasting protection against disease recurrence.
| 5 min read
New population-level data reveal unprecedented declines in cervical cancer among vaccinated cohorts, even as vaccination rates begin to slip in some countries.
| 3 min read
New findings suggest that the location of mRNA expression in the body plays a critical role in shaping T cell responses, opening the door to more precise and effective mRNA-based treatments.
This virtual two-day symposium will gather researchers to present the latest breakthroughs in cancer immunology.
| 4 min read
Cancer diagnostic technologies, advances on brain map models, pharmaceutical deals, and more led the news this week.
| 4 min read
Rare disease approvals, multi-billion-dollar deals, and more led this week’s headlines.
| 3 min read
Final results from the AMPLIFY-201 phase 1 trial highlight durable T cell responses and prolonged survival in patients with colorectal and pancreatic cancer.
| 5 min read
IO Biotech’s two-pronged cancer vaccine targets tumors and the suppressive immune cells around them, demonstrating promising results in metastatic melanoma.
Page 1 of 1 - 8 Total Items
